Investment Summary |
|
|---|---|
| Date | 2021-12-01 |
| Target | Oui Therapeutics |
| Sector | Life Science |
| Investor(s) |
Athyrium Capital Management
Polaris Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 2008 |
| PE ASSETS | 4.6B USD |
| Size | Large |
| Type | Sector Focused |
Athyrium Capital Management is a large asset manager focused on the healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium Capital was established in 2008 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 47 of 50 |
| Sector: Life Science M&A | 23 of 24 |
| Type: Venture M&A Deals | 5 of 5 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 44 of 45 |
| Year: 2021 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-19 |
InnovaCare Health
Orlando, Florida, United States InnovaCare Health improves the lives of patients and physicians through innovative solutions for value-based healthcare. Throughout its 20+ year history, InnovaCare Health has owned, operated, and managed an integrated portfolio of medical groups, health plans, medical service organizations, clinical networks, and more. InnovaCare Health was founded in 1998 is based in Orlando, Florida. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-25 |
uMotif
London, United Kingdom uMotif is a digital health company providing a patient-centric eClinical platform for clinical trials and real-world studies. Its software captures ePRO/eCOA, eConsent, symptom tracking, and wearable data to improve patient engagement, data quality, and study efficiency. uMotif was founded in 2012 and is based in London, United Kingdom. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 80 of 87 |
| Sector: Life Science M&A | 33 of 39 |
| Type: Venture M&A Deals | 51 of 57 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 72 of 78 |
| Year: 2021 M&A | 16 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-12 |
Ankyra Therapeutics
Cambridge, Massachusetts, United States Ankyra Therapeutics, a company developing cancer therapies based on tumor localized immune potentiating agents that boost anti-tumor immune responses. Ankyra was founded in 2019 and is headquartered in Cambridge, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-07 |
Freenome
South San Francisco, California, United States Freenome develops blood-based tests for early cancer detection, applying its proprietary multiomics platform, deep expertise in molecular biology and advanced machine learning. Freenome was founded in 2014 and is based in South San Francisco, California. |
Buy | - |
